Literature DB >> 27534576

In search of a target: PD-1 and PD-L1 profiling across glioma types.

Anna S Berghoff1, Matthias Preusser2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27534576      PMCID: PMC5035530          DOI: 10.1093/neuonc/now162

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  13 in total

1.  Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.

Authors:  Dirk Schadendorf; F Stephen Hodi; Caroline Robert; Jeffrey S Weber; Kim Margolin; Omid Hamid; Debra Patt; Tai-Tsang Chen; David M Berman; Jedd D Wolchok
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

Review 2.  Current State of Immune-Based Therapies for Glioblastoma.

Authors:  Michael Lim; Michael Weller; E Antonio Chiocca
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

Review 3.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

4.  Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors:  Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

5.  PD-L1 expression and prognostic impact in glioblastoma.

Authors:  Edjah K Nduom; Jun Wei; Nasser K Yaghi; Neal Huang; Ling-Yuan Kong; Konrad Gabrusiewicz; Xiaoyang Ling; Shouhao Zhou; Cristina Ivan; Jie Qing Chen; Jared K Burks; Greg N Fuller; George A Calin; Charles A Conrad; Caitlin Creasy; Krit Ritthipichai; Laszlo Radvanyi; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2015-08-30       Impact factor: 12.300

Review 6.  Prospects of immune checkpoint modulators in the treatment of glioblastoma.

Authors:  Matthias Preusser; Michael Lim; David A Hafler; David A Reardon; John H Sampson
Journal:  Nat Rev Neurol       Date:  2015-08-11       Impact factor: 42.937

7.  PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells.

Authors:  Kathleen M Mahoney; Heather Sun; Xiaoyun Liao; Ping Hua; Marcella Callea; Edward A Greenfield; F Stephen Hodi; Arlene H Sharpe; Sabina Signoretti; Scott J Rodig; Gordon J Freeman
Journal:  Cancer Immunol Res       Date:  2015-11-06       Impact factor: 11.151

8.  Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Authors:  Eric Bouffet; Valérie Larouche; Brittany B Campbell; Daniele Merico; Richard de Borja; Melyssa Aronson; Carol Durno; Joerg Krueger; Vanja Cabric; Vijay Ramaswamy; Nataliya Zhukova; Gary Mason; Roula Farah; Samina Afzal; Michal Yalon; Gideon Rechavi; Vanan Magimairajan; Michael F Walsh; Shlomi Constantini; Rina Dvir; Ronit Elhasid; Alyssa Reddy; Michael Osborn; Michael Sullivan; Jordan Hansford; Andrew Dodgshun; Nancy Klauber-Demore; Lindsay Peterson; Sunil Patel; Scott Lindhorst; Jeffrey Atkinson; Zane Cohen; Rachel Laframboise; Peter Dirks; Michael Taylor; David Malkin; Steffen Albrecht; Roy W R Dudley; Nada Jabado; Cynthia E Hawkins; Adam Shlien; Uri Tabori
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

9.  Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

Authors:  Anna Sophie Berghoff; Barbara Kiesel; Georg Widhalm; Orsolya Rajky; Gerda Ricken; Adelheid Wöhrer; Karin Dieckmann; Martin Filipits; Anita Brandstetter; Michael Weller; Sebastian Kurscheid; Monika E Hegi; Christoph C Zielinski; Christine Marosi; Johannes A Hainfellner; Matthias Preusser; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2014-10-29       Impact factor: 12.300

10.  Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.

Authors:  Silvia Darb-Esfahani; Catarina Alisa Kunze; Hagen Kulbe; Jalid Sehouli; Stephan Wienert; Judith Lindner; Jan Budczies; Michael Bockmayr; Manfred Dietel; Carsten Denkert; Ioana Braicu; Korinna Jöhrens
Journal:  Oncotarget       Date:  2016-01-12
View more
  7 in total

1.  Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines.

Authors:  Lei Zhang; John S Yu
Journal:  J Neurooncol       Date:  2019-05-31       Impact factor: 4.130

2.  Correlation of immune phenotype with IDH mutation in diffuse glioma.

Authors:  Anna Sophie Berghoff; Barbara Kiesel; Georg Widhalm; Dorothee Wilhelm; Orsolya Rajky; Sebastian Kurscheid; Philip Kresl; Adelheid Wöhrer; Christine Marosi; Monika E Hegi; Matthias Preusser
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 13.029

Review 3.  The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.

Authors:  Norbert Galldiks; Ian Law; Whitney B Pope; Javier Arbizu; Karl-Josef Langen
Journal:  Neuroimage Clin       Date:  2016-12-18       Impact factor: 4.881

Review 4.  Macrophages and microglia: the cerberus of glioblastoma.

Authors:  Alice Buonfiglioli; Dolores Hambardzumyan
Journal:  Acta Neuropathol Commun       Date:  2021-03-25       Impact factor: 7.801

5.  Multi-Omics Analysis Reveals Novel Subtypes and Driver Genes in Glioblastoma.

Authors:  Yang Yuan; Pan Qi; Wang Xiang; Liu Yanhui; Li Yu; Mao Qing
Journal:  Front Genet       Date:  2020-11-26       Impact factor: 4.599

Review 6.  The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices.

Authors:  Federica Di Cintio; Michele Dal Bo; Lorena Baboci; Elena De Mattia; Maurizio Polano; Giuseppe Toffoli
Journal:  Front Neurosci       Date:  2020-11-25       Impact factor: 4.677

Review 7.  Immune Microenvironment in Glioblastoma Subtypes.

Authors:  Zhihong Chen; Dolores Hambardzumyan
Journal:  Front Immunol       Date:  2018-05-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.